Opendata, web and dolomites

SupaSteD

Suppresion of adaptive immunity by the Salmonella effector SteD

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 SupaSteD project word cloud

Explore the words cloud of the SupaSteD project. It provides you a very rough idea of what is the project "SupaSteD" about.

c57bl    stm    director    delayed    typhi    clinical    acid    additional    causing    pathogenesis    adaptive    fever    salmonella    manipulation    wild    globally    therapeutic    holden    acute    encoded    significance    models    london    functions    mrc    mhcii    class    human    pathogen    influence    mechanistic    formulations    island    indicating    serovar    typhimurium    cells    first    showing    localised    sequence    sted    virulence    mutant    chance    t3ss    imperial    physiological    cell    levels    infection    dendritic    significantly    onset    model    enterica    surface    thereby    histocompatibility    leader    immune    supervisor    pathogens    mouse    bacteriology    activation    secretion    amino    mature    bacterial    chronic    reduces    effector    explore    natural    serovars    prof    newly    paratyphi    dna    modulator    immunity    delta    pathogenicity    world    presenting    mice    molecular    centre    found    vivo    antigen    college    vaccines    variation    gene    spi    typhoid    broad    preliminary    cmbi    group   

Project "SupaSteD" data sheet

The following table provides information about the project.

Coordinator
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE 

Organization address
address: SOUTH KENSINGTON CAMPUS EXHIBITION ROAD
city: LONDON
postcode: SW7 2AZ
website: http://www.imperial.ac.uk/

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website http://www.imperial.ac.uk/people/o.cerny/page/msca-if-supasted.html
 Total cost 195˙454 €
 EC max contribution 195˙454 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2016
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2017
 Duration (year-month-day) from 2017-09-01   to  2019-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE UK (LONDON) coordinator 195˙454.00

Map

 Project objective

In this project, I propose to characterize the influence of SteD, an effector of a globally important bacterial pathogen Salmonella enterica, on T cell development, and its potential therapeutic application. In the mouse model of S. enterica infection, the onset of the specific immune responses is delayed significantly in comparison to other bacterial pathogens. Recent work by the group of Prof. Holden, who is the supervisor of this project, a world leader in the field of Salmonella pathogenesis and the Director of the MRC Centre for Molecular Bacteriology and Infection (MRC-CMBI) at Imperial College London, identified SteD, an effector of the Type III Secretion System (T3SS) encoded by Salmonella pathogenicity island 2 (SPI-2), as the first example of a virulence factor that reduces surface-localised mature Major Histocompatibility Complex class II (MHCII) levels in Dendritic Cells. In addition, I have found an increased activation of T cells following infection of C57BL/6 mice with S. enterica serovar Typhimurium (STm) ΔsteD mutant in comparison to wild-type STm, thereby showing that SteD is an important modulator of adaptive immunity in vivo. SteD and/or its gene have a high chance of having therapeutic application. I also have obtained preliminary evidence indicating that SteD has additional functions in the manipulation of antigen-presenting cells. Therefore, I propose to use both the acute and chronic mouse models of Salmonella infection to further characterize the influence of SteD on T cell development. Furthermore, I will investigate the mechanistic and physiological significance of natural variation in the amino acid sequence of SteD among a broad range of S. enterica serovars, including the typhoid fever-causing human-adapted serovars Typhi and Paratyphi. Finally, I will explore the possible use of SteD in new formulations of DNA vaccines. These studies will provide important knowledge for the clinical application of this newly described T3SS effector.

 Publications

year authors and title journal last update
List of publications.
2019 Ondrej Cerny, David W. Holden
Salmonella SPI-2 type III secretion system-dependent inhibition of antigen presentation and T cell function
published pages: , ISSN: 0165-2478, DOI: 10.1016/j.imlet.2019.01.006
Immunology Letters 2020-01-23
2019 Camilla Godlee, Ondrej Cerny, Charlotte H. Durkin, David W. Holden
SrcA is a chaperone for the Salmonella SPI-2 type three secretion system effector SteD
published pages: 15-25, ISSN: 1350-0872, DOI: 10.1099/mic.0.000732
Microbiology 165/1 2020-01-23

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SUPASTED" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SUPASTED" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

NSTree (2020)

Understanding substrate delivery for cell wall biosynthesis in plants

Read More  

EngPTC2 (2019)

Exploring new technologies for the next generation pulse tube cryocooler below 2K

Read More  

BB-SLM (2020)

Polychromatic digital optics for structured light

Read More